Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 31.5B | 43.6B | 33.5B | 31.4B |
| Cost of revenue | 25.4B | 37.3B | 25.3B | 24.0B |
| Gross profit | 6.1B | 6.3B | 8.2B | 7.4B |
| Operating expense | ||||
| Research & development | 552.4M | 486.4M | 504.6M | 499.7M |
| Selling general and admin | 6.3B | 162.8M | 5.6B | 4.9B |
| Other operating expenses | 1.4B | 2.4B | 777.3M | 721.8M |
| Operating income | -1.9B | -3.2B | 2.1B | 1.7B |
| Non operating interest income | ||||
| Income | 1.5B | 1.5B | 1.2B | 1.1B |
| Expense | 4.0B | 3.8B | 2.9B | 2.5B |
| Other income expense | — | — | — | — |
| Pretax income | -4.9B | -7.9B | -2.2B | -801.3M |
| Tax provision | 357.5M | -1.2B | 905.4M | 159.7M |
| Net income | -5.3B | -6.7B | -3.1B | -961.0M |
| Basic EPS | -15.1 | — | -9.0 | -2.9 |
| Diluted EPS | -15.1 | — | -9.0 | -2.9 |
| Basic average shares | 335.5M | — | 335.4M | 334.9M |
| Diluted average shares | 335.5M | — | 335.4M | 334.9M |
| EBITDA | 980.6M | -2.7B | 2.3B | 3.5B |
| Net income from continuing op. | -5.3B | -6.7B | -3.2B | -965.2M |
| Minority interests | 229.9M | 3.5M | 94.8M | -138K |
| Preferred stock dividends | 0 | 0 | 0 | 0 |